Cargando…
T-cell repertoire diversity: friend or foe for protective antitumor response?
Profiling the T-Cell Receptor (TCR) repertoire is establishing as a potent approach to investigate autologous and treatment-induced antitumor immune response. Technical and computational breakthroughs, including high throughput next-generation sequencing (NGS) approaches and spatial transcriptomics,...
Autores principales: | Porciello, Nicla, Franzese, Ornella, D’Ambrosio, Lorenzo, Palermo, Belinda, Nisticò, Paola |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9773533/ https://www.ncbi.nlm.nih.gov/pubmed/36550555 http://dx.doi.org/10.1186/s13046-022-02566-0 |
Ejemplares similares
-
Role of PARP Inhibitors in Cancer Immunotherapy: Potential Friends to Immune Activating Molecules and Foes to Immune Checkpoints
por: Franzese, Ornella, et al.
Publicado: (2022) -
CD28/PD1 co-expression: dual impact on CD8(+) T cells in peripheral blood and tumor tissue, and its significance in NSCLC patients' survival and ICB response
por: Palermo, Belinda, et al.
Publicado: (2023) -
The Effect of Hypoxia and Hypoxia-Associated Pathways in the Regulation of Antitumor Response: Friends or Foes?
por: Abou Khouzam, Raefa, et al.
Publicado: (2022) -
Antigen-specificity and DTIC before peptide-vaccination differently shape immune-checkpoint expression pattern, anti-tumor functionality and TCR repertoire in melanoma patients
por: Palermo, Belinda, et al.
Publicado: (2018) -
ZEB Proteins in Leukemia: Friends, Foes, or Friendly Foes?
por: Soen, Bieke, et al.
Publicado: (2018)